Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending

@article{Wouters2017ComparingGD,
  title={Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending},
  author={O. Wouters and P. Kanavos and M. Mckee},
  journal={The Milbank Quarterly},
  year={2017},
  volume={95},
  pages={554 - 601}
}
Policy Points: Our study indicates that there are opportunities for cost savings in generic drug markets in Europe and the United States. Regulators should make it easier for generic drugs to reach the market. Regulators and payers should apply measures to stimulate price competition among generic drugmakers and to increase generic drug use. To meaningfully evaluate policy options, it is important to analyze historical context and understand why similar initiatives failed previously. Context… Expand
Is greater generic competition also linked to lower drug prices in South Korea?
  • K. Son
  • Business, Medicine
  • Health Economics Review
  • 2020
The impact of pharmaceutical tendering on prices and market concentration in South Africa over a 14-year period.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 166 REFERENCES
Effects of Reference Pricing in Pharmaceutical Markets
Does Regulation Drive Out Competition in Pharmaceutical Markets?*
...
1
2
3
4
5
...